Bones and Joints | Kidney | Pediatrics | Soft Tissue, Phase III

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumors

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumors.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Sharon Huie

sharon.huie@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Farzana Pashankar, MD, MRCP, MBBS
Professor of Pediatrics (Hematology/Oncology); Fellowship Director, Pediatric Hematology & Oncology Program; Director, Solid Tumor Program, Pediatric Hematology & Oncology Program; Children's Oncology Group Site PI, Pediatric Hematology & Oncology Program

Sub-Investigators

Last Updated
12/29/2023
Study HIC
#2000023877